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Aims: Periodontal disease is associated with adverse pregnancy outcome, but the
underlying pathophysiologic mechanism is still unknown. In this prospective, longitudinal,
non-interventional case-control study, 45 women with preterm premature rupture of
membranes and 26 controls with uncomplicated pregnancies were examined at three
time-points (T1: 20–34 weeks of gestations; T2: within 48 h after delivery; T3: 4–6 weeks
post partum). Examinations included subgingival, blood, vaginal, and placenta sampling
for microbiologic, cytokine, and histology assessment. Objective of this study was to
test the hypothesis that systemic inflammatory changes and not specific bacteria are
predominantly involved in the association between periodontal disease and adverse
pregnancy outcome.
Results: Demographic data and gestational age at T1 were comparable between
groups. While there was no correlation between vaginal and gingival fluid microbiome,
cytokine levels in the assessed compartments differed between cases, and controls.
Vaginal smears did not show a higher rate of abnormal flora in the cases at the onset of
preterm premature rupture of membranes. Number and variety of bacteria in the case
group placental membranes and vagina were higher, but these bacteria were not found
in membranes at birth.
Conclusions: On the basis of our results we speculate that an inflammatory pathway
sequentially involving periodontal tissue, maternal serum, and finally vaginal compartment
contributes to the underlying pathomechanism involved in preterm premature rupture of
membranes associated with periodontitis.
Keywords: adverse pregnancy outcome, cytokines, inflammatory mediators, periodontal inflammation,
periodontopathogenic bacteria, preterm birth, PPROM, preterm premature rupture of membranes
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INTRODUCTION
Preterm birth (PTB) is the leading cause of perinatal morbidity
and mortality in developed countries (1). About 10% of all
live births worldwide are preterm and account for 28–75% of
all perinatal deaths and over 50% of all severe developmental
disorders in children worldwide (1). Prevention of PTB would
have an extensive impact on public health and understanding its
pathogenesis would pave the way for prevention strategies.
PTB is associated with preterm labor in 40–45%, with preterm
prelabor rupture of membranes (PPROM) in 25–30%, and with
maternal or fetal indications in 30–35% (1, 2). PPROM occurs in
3% of pregnancies (2).
Ascending (asymptomatic) intrauterine infections cause an
inflammatory decidual activation resulting in preterm labor
or PPROM (3–5). Albeit this is believed to be the primary
cause of PPROM (1, 6, 7), to what extent remote infections
contribute to PTB and specifically PPROM is not known (1,
8, 9). Many of the risk factors for PTB culminate in increased
systemic inflammation which might as well result in decidual
activation (1).
Periodontal disease is known to be related to systemic
inflammation in other diseases (10). Periodontitis is an
inflammatory disease destroying tooth-supporting connective
tissue and bone. It has been linked to adverse pregnancy outcome
(APO) like PTB, low birth weight and preeclampsia (8, 11–17),
but this association is inconsistently reported to exist or not to
exist (18, 19).
The pathophysiologic mechanism of a potential association
between APO and periodontal disease remains to be elucidated
(8, 20). Possibly a common pathway of increased systemic
inflammation is responsible (8, 21), since intrauterine infection
with oral flora in PTB patients is rare (22) and bacteria are found
in the majority of elective cesareanmembranes at term, hence the
presence of bacteria may not be sufficient to cause PTB (1, 23).
Recent findings challenge the view that ascending infections
are the primary cause for PTB because the placental microbiome
profile is much more akin to the oral microbiome than to the
lower genital tract (24). Furthermore, bacteria detected in the
PTB placenta are not typically found in the lower genitourinary
tract (24). Intrauterine infections causing PTB may originate
from the mother’s mouth rather than the vagina and the oral
cavity is a major reservoir for microbial infections (25, 26).
Nevertheless, it is unclear whether the organisms need to enter
fetal tissue or whether inflammatory substances are sufficient to
potentiate PTB (27).
Microorganisms activate the immune system to release
inflammatory markers and prostaglandins stimulating uterine
contractility and matrix-degrading enzymes which lead to
PPROM (1, 7). Increased levels of inflammatory mediators in
gingival crevicular fluid (GCF) have been found in women
with APO and pro-inflammatory cytokines might be able to
precipitate labor (28–31).
The study of clinical parameters, bacteria and cytokines in
three different body compartments (mouth, vagina, blood) might
help to understand the relation between remote infections and
PTB. Therefore, the aim of the present study was to investigate
inflammatorymarkers in different body compartments in women
with PPROM compared with healthy pregnant women to test the
hypothesis that systemic inflammatory changes and not specific
bacteria are predominantly involved in the association between
periodontal disease and APO.
MATERIALS AND METHODS
Study Design and Patient Selection
This longitudinal, non-interventional, prospective case-control
study was designed and conducted as a collaboration of the
Department of Obstetrics and Gynecology and the Department
of Periodontology (University of Bern). The study protocol
was approved by the Ethics Committee of the Canton of
Bern (Nr. 091/10), and all participating women gave written
informed consent.
Participants were enrolled in the Department of Obstetrics
and Gynecology from November 2011 to August 2013 when
either presenting with PPROM or during regular pregnancy
visits. Cases were defined as women with PPROM between 20
0/7 and 34 0/7 weeks of gestation, and controls had uneventful
pregnancies at the time of inclusion and were recruited in the
same time frame (timepoint T1).
Cases and controls were examined at three distinct time points
T1, T2, T3 (T1: after inclusion; T2: within 48 h after delivery;
T3: 4–6 weeks post partum). Women missing two out of three
examinations were defined as dropouts. Each exam included
1. Oral investigation: Periodontal Screening Index (PSI),
collection of gingival crevicular fluid [GCF; CRP,
cytokines (IL-1b, IL-6, IL-8, IL-10)], subgingival bacterial
sampling, Multiplex-PCR
2. Blood samples: CRP, blood count, cytokines (IL-1b, IL-6, IL-
8, IL-10)
3. Vaginal exam: vaginal and cervical swabs [gram stain (Nugent-
Score), microbiologic culture and PCR], CRP, cytokines (IL-
1b, IL-6, IL-8, IL-10), Multiplex-PCR
4. Additionally, at T2 placental membranes were examined
microbiologically [gram stain (Nugent-Score), microbiologic
culture and PCR] and histopathologically.
Women with PPROM received antibiotic treatment
(clindamycin or amoxicillin/clavulanic acid if group B
streptococcal status was positive or unknown) for 10 days.
Tocolysis was administered. Antenatal glucocorticoids
(betamethasone 12mg i.m., repeated once after 24 h) were
given to promote fetal lung maturation. Samples were taken
before antibiotic, tocolytic, and glucocorticoid treatment on
initial exam after admission. Labor was induced or cesarean
section done at 34 0/7 weeks of gestation if women did not
develop spontaneous labor, persistent vaginal bleeding, signs of
amnion infection, or non-reassuring fetal status.
Statistical power analysis based on data including 185 patients
at 6 months post-partum (32). A 50% difference in bacterial load
between women delivering preterm and controls was anticipated.
Based on a significance level of p < 0.01 and 1-β = 0.85 we
assumed to need 40 women in each group to declare a difference.
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Oral Investigation
For microbiological sampling subgingival plaque was collected
from each first molar in all quadrants with endodontic
paper points (ISO 055, Dentsply Maillefer, Montigny Le
Bretonneux, France, www.dentsply.fr) inserted into the
gingival crevice for 15 s. Paper points pooled and stored at
−20◦C until assayed for presence of periodontopathogens.
The PSI (Periodontal Screening Index) was recorded.
GCF (Gingival crevicular fluid) samples were taken by
sterile paper strips (Periopaper, Oraflow Inc., Smithtown,
NY, USA, www.oraflow.com) and stored at −80◦C until
assayed. The oral investigations’ results have been published
elsewhere (12).
Vaginal and Peripheral Blood Analysis,
Histopathology
Swabs were taken from the vagina and cervix, respectively, during
speculum exam for routine microbiological culture, PCR, and
gram stain and stored in the appropriate media. Blood samples
were examined in the central laboratory and histopathologic
assessment was provided from the Department of Pathology
(University Hospital Bern).
Microbiologic Analysis
Multiplex-PCR: DNA was extracted by using the Chelex
method (12). For detection of periodontopathogens
the microIDent R©plus11 test (Hain Lifescience, Nehren,
Germany, www.hain-lifescience.de) was used according to
the manufacturer’s description. The test is able to identify 11
periodontopathogenic bacterial species after two PCR runs and a
subsequent reverse hybridization (12).
Vaginal samples were assessed via conventional
microbiological analysis (cultures including aerobes and
anaerobes, Listeria and Candida sp.) and PCR (Chlamydia,
Mycoplasma, Ureaplasma, and Treponema pallidum). Bacterial
vaginosis (BV) was diagnosed in gram stain samples according
to Nugent criteria and smears were categorized as abnormal
according to Donders et al. (33).
Analysis of Inflammatory Mediators
Before analyzation, samples (GCF, blood serum, vaginal fluid)
were eluted at 4◦C overnight into 750 µl phosphate-buffered
saline containing proteinase inhibitors (Sigma-Aldrich, St. Louis,
MO, USA, www.sigmaaldrich.com). From the eluates, IL-1b, IL-
6, IL-8, IL-10, and CRP were determined by using commercially
TABLE 1 | Demographic data, preexisting conditions, previous and current pregnancies.
Cases
(n = 45)
Controls
(n = 26)
p=
Age (years; Median, Range) 35.0 (24–48) 35.0 (25–42) 0.608* n.s.
Race (% caucasian) 91 81 0.272◦ n.s.
BMI (kg/m2; Median, Range) 22.2 (16.1–44.3) 22.2 (18–40.4) 0.989** n.s.
Primipara (%) 58 58 1.000◦ n.s.
Preexisting conditions (n =)
- Systemic diseases 5 4
- Hypertensive disease 1 0
- Obesity 3 3
- HIV-positive 1 0
Previous pregnancies
- Miscarriage 15 8
- Induced abortion 3 2
- Preterm delivery 1 1
- Intrauterine fetal death 1 1
- Chorioamnionitis 1 0
- Preeclampsia 1 1
- PPROM 1 2
- GTD 0 1
Current pregnancy
- Premature labor 26 0
- Amnion infection syndrome 9 0
- Vaginal bleeding 4 2
- Polyhydramnios 1 0
- Pregnancy-induced hypertension 0 2
- Gestational diabetes 0 1
- Preeclampsia 0 1
*t-test; **Mann-Whitney-U-Test; ◦Fisher’s Exact test; n.s., not statistically significant.
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available enzyme-linked immunosorbent assay (ELISA) kits
(R&D Systems Europe Ltd., Abingdon, UK, www.rndsystems.
com). The detection levels of the kits were 2 pg (CRP: 10 pg).
Data Analysis
Demographic data, obstetric outcomes and laboratory results
were compared with the student’s t-test and the Mann-Whitney-
U-Test, respectively. The Mann-Whitney-U Rank Sum Test was
used comparing medians if the normality test (Kolmogorov-
Smirnov) failed or if the normality test passed but the equal
variance test (Levene Median test) failed. If both tests passed the
student’s t-test was used for comparing means. Qualitative data
were analyzed with Fisher’s Exact Test for independent groups.
The statistical tests used are specified in the respective tables.
Statistical analysis was performed by using Graph Pad Prism
6 (GraphPad Software, Inc., La Jolla, CA, USA). The level of
significance was set at p= 0.05.
RESULTS
Seventy-one women were included in the study analysis of whom
45 were PPROM-cases and 26 controls. In the test group four
women dropped out because they did not prove to have ruptured
membranes (n = 2), did not deliver in our facility or were not
followed-up according to the protocol. In the control group
11 women dropped out as they delivered in other hospitals (n
= 3), developed chorioamnionitis (n = 2), had a severe pre-
eclampsia, intrauterine death, preterm contractions, or refused
further participation in the study (n= 3).
Study population and controls were comparable as they did
not differ in regard with age, race, BMI, parity, and preexisting
conditions (Table 1).
Characteristics of previous and current pregnancies were
similar in both groups, too, except from premature labor, and
amnion infection syndrome which were understandably more
frequent in the test group (Table 1).
As expected, pregnancies lasted significantly shorter and
birth weights were significantly lower in the case group.
There was only a tendency toward a higher rate of cesarean
deliveries in the case group which was not statistically
significant (Table 2).
The neonates’ gender did not differ in both groups.
Interestingly, no difference in the rate of newborns with a
5-min-Apgar lower than 7 was found in both groups and
an arterial umbilical cord pH lower than 7.15 was even
more frequent in the control group. Expectedly, referral to
the Neonatology department occurred more frequently in the
case group (Table 2). Likewise respiratory distress syndrome,
neonatal infection and sepsis rates were higher in the case
group newborns.
In vaginal smears, gram stain showed no statistically
significant difference in the rate of abnormal flora/bacterial
vaginosis (BV) (34) between the groups at T1 (onset of PPROM).
At T2 (delivery) the abnormal flora/BV rate was significantly
higher in the case group most likely due to ascending bacteria
because of the state of ruptured membranes. At T3 no difference
in the rate of abnormal flora/BV was found for both groups.
The variety and number of bacteria found in cultures were
increased in the case group at T1 and (possibly affected by the
state of ruptured membranes) remained increased at T2 and even
T3 (Table 3).
Smears from the membranes showed again a larger
number and variety of bacteria in the case group membranes
(Table 3). Remarkably, in only one patient the same bacterium
(Haemophilus influenzae) was found in the vagina at T1 and
in the placenta/membranes at delivery (T2). Chorioamnionitis
was diagnosed histopathologically significantly more often in the
case placentae (Table 3).
TABLE 2 | Current pregnancy.
Cases
(n = 45)
Controls
(n = 26)
p =
Gestational weeks at PPROM/study inclusion Median 31 + 0 28 + 1 0.033**
Range 22 + 5–35 + 1 21 + 1–35 + 1
Gestational weeks at delivery Median 32 + 2 39 + 1 <0.001**
Range 25 + 2–35 + 1 35 + 2–41 + 3
Complications at delivery n =
- Retained placenta 3 3
- Obstructed labor 1 2
- Post partum hemorrhage 1 0
- Prolapsed umbilical cord 1 0
Cesarean section rate % 47 35 0.455◦ n.s.
Female neonates % 42 46 0.813◦ n.s.
Birth weight Grams 1,666 3,348 <0.001*
APGAR at 5′ < 7 % 21 12 0.367◦ n.s.
pH art. <7.15 % 2 15 0.038◦
Transfer to NICU % 94 8 <0.001◦
*t-test; **Man-Whitney-U-Test; ◦Fisher’s Exact test; n.s., not statistically significant.
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TABLE 3 | Microbiota and histopathology.
Source Legend Timepoint 1
cases
Controls p = Timepoint 2
cases
Controls p = Timepoint 3
cases
Controls p =
Gram stain Vagina % normal/
abnormal/BV
51/33/16 74/9/17 n.s. 19/68/13 65/29/6 0.001 31/50/19 54/33/13 n.s.
Culture spec. Vagina 5× E.coli
1× Hämoph.inf.
1× Gardnerella
1× Staphyloc.
1× Strept.milleri
6× Mix.flora
2× Gardner.
2× Mix.flora
5× E.coli
1× Enterococ.
1× Peptostrept.
1× Klebsiella 1×
Enterobact.
1× Fungus
8× Mix.flora
5× Mix.flora 3× E.coli
2×Strept.mill.
2× Gardner.
1× Klebsiella
1× Staph.aur.
11× Mix.flora
1× E.coli
8× Mix.flora
Candida Vagina n = 3 0 n.s. 0 1 n.s. 0 0 n.s.
GBS Vagina n = 5 1 n.s. 0 0 n.s. 3 2 n.s.
Mycoplasma Vagina n = 1 0 n.s. 1 0 n.s. 0 0 n.s.
Ureaplasma Vagina n = 11 8 n.s. 2 5 0.026 0 4 n.s.
Culture
growth
Membranes n = 12 7 n.s.
Culture spec. Membranes 4× E.coli
2× Enterococ.
3× Ureaplas.
1× Hämoph.inf
1× Strept.vir.
1× Peptostrept.
1× Enterobact.
1× Bact.fragil.
3× Mix.flora
1× E.coli
1× Serratia
2× Ureaplas.
1× Bact.fragil.
Histology Placenta %
Chorioamnionitis
40 0 0.001
All p-values: Fisher’s exact test. n.s., not statistically significant.
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TABLE 4 | Cytokines: comparison of case vs. control group at the 3 timepoints.
Cytokine Source Cases vs. Controls
T1 T2 T3
IL1b Blood n.s. n.s. n.s.
Gingiva n.s. ↓ (12 vs. 36) n.s.
Vagina n.s. n.s. n.s.
IL6 Blood n.s. n.s. n.s.
Gingiva n.s. n.s. n.s.
Vagina ↑ (281 vs. 32) n.s. n.s.
IL8 Blood ↑ (126 vs. 24) n.s. n.s.
Gingiva ↓ (105 vs. 280) n.s. n.s.
Vagina n.s. n.s. n.s.
IL10 Blood n.s. n.s. n.s.
Gingiva ↑ (30 vs. 10) n.s. n.s.
Vagina ↑ (33 vs. 9) ↑ (50 vs. 22) n.s.
CRP Blood n.s. n.s. n.s.
Gingiva ↓ (105 vs 294) n.s. n.s.
Vagina n.s. ↓ (3,088 vs. 4,817) ↓ (1,442 vs. 2,070)
↑ : significantly higher levels; ↓ : significantly lower levels; n.s., not significant.
Brackets: Means in pg/ml. All p-values: Mann-Whitney-U-test.
Neither Chlamydia nor Gonococcus or Listeria were detected
in all groups at all timepoints. Candida, group B streptococci,
mycoplasma and ureaplasma colonization were not statistically
different between both groups at all timepoints, except
ureaplasma at T2 which was even higher in controls than in
women with PPROM (Table 3).
Leucocyte count was significantly higher in the
test group at T1 and T2, while 6 weeks after delivery
at T3 there was no significant difference. Leucocytes
increased from T1 to T2 in the test group, but not in the
control group.
The comparison of cytokine levels in the three
body compartments at the three timepoints showed
(Table 4, Figures 1 – 3) at
- T1: The case patients had higher levels of pro-inflammatory
IL-6 in the vagina and pro-inflammatory IL-8 in the blood,
lower levels of IL-8 and CRP in the gingiva, and higher levels of
anti-inflammatory IL-10 in gingiva and vagina
- T2: The case patients had increased levels of pro-inflammatory
IL-1b in the gingiva, increased levels of IL-10 and a decreased
CRP in the vagina
- T3: The case patients only showed lower CRP levels in
the vaginal.
All other parameters in blood, vaginal and gingival fluid were not
significantly different at the three timepoints (Table 4, Figures 1–
3). However, from T1 to T2 IL-1b and IL-8 decreased in gingiva
while IL-6 increased in the blood and CRP increased in the
vagina. These interleukin patterns might be in line with the
cascade theory: Inflammatory cytokines already start decreasing
in the mouth while they increase in blood and vagina reflecting a
chronological process starting in the oral cavity.
DISCUSSION
Our study focuses on the relationship between periodontitis
and PPROM. Three different body compartments were therefore
studied at three time points. The main finding is the difference
in cytokine levels in different compartments in the case group at
the time of PPROM as compared to controls. This means that
an inflammatory process is in progress, and cytokine patterns
suggest this to be initiated in the periodontal compartment,
consecutively encroaching on further body compartments.
However, this does not occur via bacterial spread since nucleic
acid based methods and microbiologic cultures did neither reveal
an association of oral and vaginal nor of vaginal and placental
bacterial colonization.
Predicting and identifying women at risk for delivering
preterm is challenging. A relation between periodontitis and
APO has been suggested (11, 15), but the pathophysiologic link
is not established. Oral inflammatory mediator changes have
been reported in APO (8, 28, 35–37), but none of these studies
focused on women with PPROM or cytokine levels in different
body parts. A systematic approach examining systemic and
local compartments might reveal pathophysiologic links between
remote infection and PPROM.
The comparison of cytokine levels in the three body
compartments at three timepoints showed significant differences
between PPROM patients and controls. At the onset of PPROM
the periodontal inflammation seems to already decline since
pro-inflammatory IL-8 and CRP are decreased compared to
controls and an immune response is already initiated as anti-
inflammatory IL-10 (38, 39) reactively increases in the gingiva.
At the same time pro-inflammatory IL-8 and IL-6, respectively,
are increased in blood and vagina. Both cytokines are early
markers of a beginning inflammation (40). This suggests that
inflammation starts in the periodontal compartment and already
begins to resolve, while in peripheral blood and vagina it is still
ongoing in terms of an inflammatory cascade. From T1 to T2
the same situation is found: while inflammatory markers (IL-
1b and IL-8) further decrease in the gingiva, IL-6 increases in
the blood and both CRP and IL-10 increase in the vagina. The
informative value of the differences in cytokine levels at T1 is
emphasized by the condition that at 6 weeks post partum (T3)
interleukin levels in both groups did not differ significantly.
The inflammatory response seems to regress which is consistent
with the systemic inflammatory hypothesis. The finding of an
increased anti-inflammatory cytokine IL-10 in the vagina at T1
and T2 might be explained by the fact that rising IL-10 levels in
the vaginal fluid reflect the initiation of the birth process (41, 42),
besides being associated with intraamniotic infection (43).
The oral investigations’ results showed an association between
periodontal status and PPROM and oral periodontopathogens
were more prevalent in the PPROM women (12). Importantly,
although periodontopathogenic bacteria were detected in vaginal
samples, in none of the women these bacteria were found in both
the vagina and the mouth concomitantly (12), corroborating the
hypothesis that not bacterial spread but systemic inflammation
might be a contributing factor in developing PPROM. This is
further supported by the finding that abnormal flora and bacterial
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FIGURE 1 | Comparison of cytokine levels in PPROM women (cases) vs. controls at timepoint 1. *statistically significant.
FIGURE 2 | Comparison of cytokine levels in PPROM women (cases) vs. controls at timepoint 2. *statistically significant.
vaginosis were equally frequent in both the cases and the controls,
respectively, at the occurrence of PPROM (timepoint 1). Vaginal
bacterial dysbalance seems not to be the exclusive cause for
PPROM. The variety and number of bacteria found in cultures
was increased in the case group at T1, but remarkably in only
one patient the same bacterium has been affirmed in both the
vagina at T1 and the placenta smears at T2 (delivery), which again
is in conflict with the hypothesis that ascending infection is the
primary mechanism for PPROM.
Recent findings showing that the placental microbiome
profile is much more akin to the oral microbiome than to
the lower genital tract (24) do not support the theory that
ascending infection is the primary cause of PPROM. Likewise,
microbiome profile at PPROM does not correlate with latency
duration supporting our notion that systemic inflammation may
rather play a role in the onset of PPROM than microbiota
dysbalance (44). Furthermore, direct spread of oral bacteria to
the reproductive tract is unlikely since PTB is rarely associated
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FIGURE 3 | Comparison of cytokine levels in PPROM women (cases) vs. controls at timepoint 3. *statistically significant.
with intrauterine infection with oral flora (22), and bacteria
are mostly found in term membranes without causing PTB
(1, 23). In our patients, periodontopathogens found in the
gingiva have not been verified in the placenta/membrane swabs
(12) and no difference was found in the rate of abnormal
flora and bacterial vaginosis between cases and controls at
the time of PPROM. Moreover, in only one patient one of
the bacteria found in the vagina at T1 was verified in the
placenta/membranes at T2. All these findings argue against the
theory of direct spread of bacteria as the causative mechanism
of PPROM. Accordingly, recent studies have shown the gut
microbiome being linked to several diseases and although the
exact mechanism is not fully understood a systemic cytokine
release has been demonstrated and made accountable for
disease occurrence (45, 46). A more extensive investigation
of the microbiome-inflammation-interaction in different body
compartments is desirable.
A strength of our study is the unique study design with a
comprehensive approach including simultaneous examination of
different body compartments, microbiological and nucleic acid
based assessment and comparison of inflammation markers, in
parallel with clinical periodontological assessment at different
timepoints. The use of the multiplex method is considered
particularly convenient (47).
A weakness is that we have no data of women at “T0,”
i.e., before PPROM becomes clinically evident. In particular,
an early timepoint for analysis in the first trimester or even
before onset of pregnancy would be valuable in order to
have the whole picture and understand the mechanism how
periodontitis may cause PPROM and APO. Unfortunately, due
to the low incidence of PPROM and the high expenditure
such a prospective study would be difficult to realize. The lack
of published data and the complexity of recruiting women
for examination at three time points impeded a sound power
analysis and inclusion of a large number of patients. Thus, the
limited number of women in our study might explain why
differences have not been observed among some of the measured
parameters, and maternal plasma cytokine concentrations are
difficult to interpret in APO patients (48). Moreover, paper
points were used for samplings of subgingival plaque. Since
they do not allow to collect the biofilm but only planktonic
bacteria, use of a courette might have been the better choice for
sample collection.
In summary, the results of our study can be interpreted in
line with our initial hypothesis that systemic inflammation—
initiated and triggered by periodontal disease—might play a role
in developing PPROM. Bacterial spread or ascension seem not
to represent the exclusive pathophysiologic cause for PPROM.
There is a systemic inflammation in progress at the time of
PPROM and we speculate that the inflammatory pathway rather
than ascending infection alone contributes to PPROM and—
consecutively—PTB.
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